BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2841078)

  • 1. Histological grading, DNA content, cell proliferation and survival of patients with astroglial tumors.
    Zaprianov Z; Christov K
    Cytometry; 1988 Jul; 9(4):380-6. PubMed ID: 2841078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry in brain tumors. I. Ploidy abnormalities.
    Christov K; Zapryanov Z
    Neoplasma; 1986; 33(1):49-55. PubMed ID: 3008010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
    Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
    Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image analysis of nuclear DNA content and morphometric characteristics of the tumor cells in human astrocytomas.
    Saito A; Yoshii Y; Nose T
    Noshuyo Byori; 1994; 11(2):143-6. PubMed ID: 7894615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical study of S-phase cells in human gliomas].
    Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
    No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas.
    Sallinen SL; Sallinen P; Haapasalo H; Kononen J; Karhu R; Helén P; Isola J
    Am J Pathol; 1997 Dec; 151(6):1799-807. PubMed ID: 9403731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow-cytophotometry of nuclear DNA in biopsies of 45 human gliomas and after primary culture in vitro.
    Spaar FW; Ahyai A; Spaar U; Gazsó L; Zimmermann A
    Clin Neuropathol; 1986; 5(4):157-75. PubMed ID: 3757347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
    Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
    Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
    Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P
    Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human astrocytomas.
    Coons SW; Johnson PC; Pearl DK
    Neurosurgery; 1994 Jul; 35(1):119-25; discussion 125-6. PubMed ID: 7936132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry).
    Kasai H; Kawamoto K
    Noshuyo Byori; 1995 Mar; 12(1):75-82. PubMed ID: 7795734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
    Lindahl B; Alm P; Killander D; Långström E; Tropé C
    Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleomorphic xanthoastrocytoma: DNA flow cytometry and outcome analysis of 12 patients.
    Rostomily RC; Hoyt JW; Berger MS; Kros JM; Alvord EC; Wilkins P; Rabinovitch P
    Cancer; 1997 Dec; 80(11):2141-50. PubMed ID: 9392337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
    Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas.
    Birlik B; Canda S; Ozer E
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):532-8. PubMed ID: 16972887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.